Evidence map›Paper›PMID 28832876›Full record

Trial reportJAMA psychiatry2017

Addiction Potential of Cigarettes With Reduced Nicotine Content in Populations With Psychiatric Disorders and Other Vulnerabilities to Tobacco Addiction.

Stephen T Higgins, Sarah H Heil, Stacey C Sigmon, Jennifer W Tidey, Diann E Gaalema, John R Hughes, Maxine L Stitzer, Hanna Durand, Janice Y Bunn, Jeff S Priest and 8 more

Erratum issuedAbstract readRandomized Controlled Trial
In one paragraph

Trial report in JAMA psychiatry, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 100 papers, 5 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
100citing papers in PubMed, 5 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

100 citing papers in PubMed, 5 syntheses or guidelines pooled it.

  1. Pooled it
  2. Regulatory Approaches and Implementation of Minimally Addictive Combusted Products.Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco · 2022
    Pooled it
  3. Pooled it
  4. Nicotine Reduction in Cigarettes: Literature Review and Gap Analysis.Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco · 2019
    Pooled it
  5. Pooled it
  6. Trial
  7. Trial
  8. Trial
  9. Trial
  10. The Impact of Reducing Nicotine Content on Adolescent Cigarette Smoking and Nicotine Exposure: Results From a Randomized Controlled Trial.Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco · 2023
    Trial
  11. Manipulation of Menthol and Nicotine Content in Cigarettes: Effects on Smoking Behavior and Toxicant Exposure in Women Menthol Smokers.Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco · 2023
    Trial
  12. Trial
  13. Trial
  14. Trial
  15. Trial
  16. Trial
  17. Trial
  18. Effects of Reduced-Nicotine Cigarettes Across Regulatory Environments in the Experimental Tobacco Marketplace: A Randomized Trial.Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco · 2021
    Trial
  19. Switching to Progressively Reduced Nicotine Content Cigarettes in Smokers With Low Socioeconomic Status: A Double-Blind Randomized Clinical Trial.Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco · 2021
    Trial
  20. Trial

40 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

18 authors.

Stephen T HigginsUniversity of Vermont Tobacco Center of Regulatory Science, Departments of Psychiatry and Psychological Science, Burlington.
Sarah H HeilUniversity of Vermont Tobacco Center of Regulatory Science, Departments of Psychiatry and Psychological Science, Burlington.
Stacey C SigmonUniversity of Vermont Tobacco Center of Regulatory Science, Departments of Psychiatry and Psychological Science, Burlington.
Jennifer W TideyCenter for Alcohol and Addiction Studies, Brown University, Providence, Rhode Island.
Diann E GaalemaUniversity of Vermont Tobacco Center of Regulatory Science, Departments of Psychiatry and Psychological Science, Burlington.
John R HughesUniversity of Vermont Tobacco Center of Regulatory Science, Departments of Psychiatry and Psychological Science, Burlington.
Maxine L StitzerDepartment of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, Baltimore, Maryland.
Hanna DurandUniversity of Vermont Tobacco Center of Regulatory Science, Departments of Psychiatry and Psychological Science, Burlington.
Janice Y BunnUniversity of Vermont Tobacco Center of Regulatory Science, Departments of Psychiatry and Psychological Science, Burlington.
Jeff S PriestUniversity of Vermont Tobacco Center of Regulatory Science, Departments of Psychiatry and Psychological Science, Burlington.
Christopher A ArgerUniversity of Vermont Tobacco Center of Regulatory Science, Departments of Psychiatry and Psychological Science, Burlington.
Mollie E MillerCenter for Alcohol and Addiction Studies, Brown University, Providence, Rhode Island.
Cecilia L BergeriaUniversity of Vermont Tobacco Center of Regulatory Science, Departments of Psychiatry and Psychological Science, Burlington.
Danielle R DavisUniversity of Vermont Tobacco Center of Regulatory Science, Departments of Psychiatry and Psychological Science, Burlington.
Joanna M StreckUniversity of Vermont Tobacco Center of Regulatory Science, Departments of Psychiatry and Psychological Science, Burlington.
Derek D ReedDepartment of Applied Behavioral Science, University of Kansas, Lawrence.
Joan M SkellyUniversity of Vermont Tobacco Center of Regulatory Science, Departments of Psychiatry and Psychological Science, Burlington.
Lauren TursiUniversity of Vermont Tobacco Center of Regulatory Science, Departments of Psychiatry and Psychological Science, Burlington.

Funding

Vermont Center on Behavior and HealthP20GM103644 · NIGMS · UNIVERSITY OF VERMONT & ST AGRIC COLLEGE · PI SIGMON, STACEY C · 2013 to 2022
$21.3M
Vermont Center on Tobacco Regulatory ScienceP50DA036114 · NIDA · UNIVERSITY OF VERMONT & ST AGRIC COLLEGE · PI HIGGINS, STEPHEN T · 2013 to 2017
$19.1M
NIDA NIH HHS P50 DA036114NIGMS NIH HHS P20 GM103644
6 · The paper itself

Abstract

Importance: A national policy is under consideration to reduce the nicotine content of cigarettes to lower nicotine addiction potential in the United States. Objective: To examine how smokers with psychiatric disorders and other vulnerabilities to tobacco addiction respond to cigarettes with reduced nicotine content. Design, Setting, and Participants: A multisite, double-blind, within-participant assessment of acute response to research cigarettes with nicotine content ranging from levels below a hypothesized addiction threshold to those representative of commercial cigarettes (0.4, 2.3, 5.2, and 15.8 mg/g of tobacco) at 3 academic sites included 169 daily smokers from the following 3 vulnerable populations: individuals with affective disorders (n = 56) or opioid dependence (n = 60) and socioeconomically disadvantaged women (n = 53). Data were collected from March 23, 2015, through April 25, 2016. Interventions: After a brief smoking abstinence, participants were exposed to the cigarettes with varying nicotine doses across fourteen 2- to 4-hour outpatient sessions. Main Outcomes and Measures: Addiction potential of the cigarettes was assessed using concurrent choice testing, the Cigarette Purchase Task (CPT), and validated measures of subjective effects, such as the Minnesota Nicotine Withdrawal Scale. Results: Among the 169 daily smokers included in the analysis (120 women [71.0%] and 49 men [29.0%]; mean [SD] age, 35.6 [11.4] years), reducing the nicotine content of cigarettes decreased the relative reinforcing effects of smoking in all 3 populations. Across populations, the 0.4-mg/g dose was chosen significantly less than the 15.8-mg/g dose in concurrent choice testing (mean [SEM] 30% [0.04%] vs 70% [0.04%]; Cohen d = 0.40; P < .001) and generated lower demand in the CPT (α = .027 [95% CI, 0.023-0.031] vs α = .019 [95% CI, 0.016-0.022]; Cohen d = 1.17; P < .001). Preference for higher over lower nicotine content cigarettes could be reversed by increasing the response cost necessary to obtain the higher dose (mean [SEM], 61% [0.02%] vs 39% [0.02%]; Cohen d = 0.40; P < .001). All doses reduced Minnesota Nicotine Withdrawal Scale total scores (range of mean decreases, 0.10-0.50; Cohen d range, 0.21-1.05; P < .001 for all), although duration of withdrawal symptoms was greater at higher doses (η2 = 0.008; dose-by-time interaction, P = .002). Conclusions and Relevance: Reducing the nicotine content of cigarettes may decrease their addiction potential in populations that are highly vulnerable to tobacco addiction. Smokers with psychiatric conditions and socioeconomic disadvantage are more addicted and less likely to quit and experience greater adverse health impacts. Policies to reduce these disparities are needed; reducing the nicotine content in cigarettes should be a policy focus.

Indexed as

Smoking PreventionTobacco Use DisorderAdultBehavior, AddictiveFemaleHumansMaleMental DisordersNicotineOutcome Assessment, Health CareSmoking CessationTobacco ProductsTobacco Use Cessation DevicesNicotine

Identifiers

PMID28832876
PMCPMC5710465

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.